Q1 2019 Results Slides - May 9 2019 Analysts Call

Issue link: https://resources.liminalbiosciences.com/i/1114939

Contents of this Issue


Page 1 of 10

© Prometic Life Sciences Inc. 2019 2 Safe Harbour Forward Looking Statement This presentation contains forward-looking statements about Prometic's objectives, strategies and businesses that involve risks and uncertainties. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, Prometic's ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of Prometic to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations in the Annual Information Form for the year ended December 31, 2018, under the heading "Risk Factors". As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations. All amounts are in Canadian dollars unless indicated otherwise. Copyright notice The information contained in this presentation (including names, images, logos and descriptions portraying Prometic's products and/or services) is the property of Prometic Life Sciences Inc., of its divisions and / or of its subsidiaries ("Prometic") and is protected by copyright, patent and trademark law and / or other intellectual property rights. Neither this presentation nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including printing and photocopying, or by any information storage or retrieval system without prior permission in writing from Prometic. Disclaimer Prometic reserves the right to make improvements, corrections and/or changes to this presentation at any time.

Articles in this issue

view archives of Webcasts - Q1 2019 Results Slides - May 9 2019 Analysts Call